mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.062 |
0.3 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |